Introduction
============

Ever since the release of the American College of Radiology Breast Imaging Reporting and Data System (ACR BI-RADS) lexicon for ultrasonography (US) in 2003, studies have proven it to have excellent diagnostic performance for breast masses, and it has been universally applied to daily practice \[[@b1-usg-16012]-[@b4-usg-16012]\]. In addition to the differential diagnosis of breast masses, US BI-RADS has contributed to standardization of imaging reports and patient management. However, many US descriptors are used for describing a breast lesion, with each descriptor containing different predictability for malignancy, and a consensus has not been reached on which descriptors have more significance in predicting malignancy \[[@b5-usg-16012]\]. In addition, US has an inherent limitation of interobserver and intraobserver variability that leads to differences among operators in both image acquisition and interpretation.

As a way to overcome the complexity of applying US descriptors and the interobserver variability of breast US, a recent study has applied computer-aided diagnosis to breast US for assistance in either lesion detection or the decision-making process during practice \[[@b6-usg-16012]\]. It has been reported that the diagnostic performance of radiologists can be improved by proper application of these computer-aided programs \[[@b7-usg-16012]\]. S-Detect is a recently developed image-analytic program that provides assistance in morphologic analysis of breast masses seen on breast US according to the US BI-RADS descriptors and final assessment. This program can guide in deciding upon the next management for the patient, which is expected to be helpful in everyday practice. To the present, there are no studies evaluating the diagnostic performance or the degree of agreement of S-Detect with radiologists who are dedicated to breast imaging.

Therefore, the purpose of this study was to evaluate the diagnostic performance of S-Detect when applied to breast US, and determine the degree of agreement with an experienced radiologist specializing in breast imaging.

Materials and Methods
=====================

This study was of a prospective design and was approved by the Institutional Review Board of Severance Hospital, Seoul, Korea. Informed consent was obtained from all patients for study inclusion.

Patients
--------

A total of 181 consecutive women with 201 breast masses who were scheduled for breast US examinations, US-guided core needle biopsy, or surgical excision from June to August 2015 gave consent to be included in this study. Among them, six women were excluded because they had non-mass lesions in the breast detected on US, since image analysis of these non-mass lesions was difficult to fit in the US BI-RADS lexicon, which is mostly intended for localized breast masses. Ultimately, 192 breast masses in 175 women were included in this study. The mean age of the women was 46.6±13.3 years (range, 18 to 81 years). The mean size of the breast masses included was 14.7±9.7 mm (range, 5 to 52 mm). Of the 192 breast masses, 77 (40.1%) were palpable, and one (0.5%) presented with bloody nipple discharge.

US Examination and Biopsy
-------------------------

US examinations were performed using a 3-12-MHz linear transducer (RS80A with Prestige, Samsung Medison, Co. Ltd., Seoul, Korea). Two staff radiologists (J.H.Y. and E.-K.K.) with 7 and 19 years of experience in breast imaging were involved in image acquisition. Both radiologists were aware of the clinical and mammographic features and had access to the prior US examinations before US examination. Bilateral whole breast examinations were routinely performed. When a breast mass was detected, routine scanning protocols included transverse and longitudinal scanning of the breast mass, still-images recorded with and without calipers used for size measurements. For image analysis using S-Detect, video clips were recorded with the US machine, including the entire mass and surrounding normal breast parenchyma during one-directional movement of the probe, starting at one end and ending at the other end of the mass. US-guided biopsy was performed after US examinations by the same radiologist who had performed breast US.

Image Review and Application of S-Detect
----------------------------------------

US features of the breast masses were retrospectively analyzed by one staff radiologist (J.H.Y.) who has 7 years of experience in breast imaging, following the fourth edition of ACR BI-RADS lexicon and final assessment categories: shape, margin, echo pattern, orientation, lesion boundary, and posterior features \[[@b4-usg-16012]\]. US features regarding calcification were not analyzed due to the limited data analytical ability of S-Detect. The radiologist chose and recorded the most appropriate term for each descriptor. Final assessments were made for each breast mass using one of the assessment categories of BI-RADS: category 2, benign; 3, probably benign; 4a, low suspicion for malignancy; 4b, intermediate suspicion for malignancy; 4c, moderate concern for malignancy; and 5, highly suggesting malignancy.

For data acquisition from S-Detect, the same radiologist who had reviewed the sonograms for analysis retrospectively applied S-detect to the same image used for grayscale US feature analysis to each breast mass. A region-of-interest (ROI) was drawn along the border of the mass ([Fig. 1](#f1-usg-16012){ref-type="fig"}), either automatically by the US unit or manually when the boundary that was automatically drawn by S-Detect was considered insufficient by the radiologist. US features according to the US BI-RADS lexicon and final assessments were automatically analyzed and visualized by S-Detect, which was recorded for data analysis. Final assessments from S-Detect were in dichotomized form: possibly benign and possibly malignant.

S-Detect applies a novel feature extraction technique and support vector machine classifier that classifies breast masses into benign or malignant according to the proposed feature combinations integrated according to the US BI-RADS \[[@b8-usg-16012]\]. Features used for US feature analysis in S-Detect are as follows: shape differences, echo and texture features using spatial grey-level dependence matrices, intensity in the mass area, gradient magnitude in the mass area, orientation, depth-width ratio, distance between mass shape and best fit ellipse, average gray changes or histogram changes between tissue/mass area, comparison of gray value of left, posterior, and right under the lesion, the number of lobulated areas/protuberances/depressions, lobulation index, and elliptic-normalized circumference \[[@b8-usg-16012]\].

Data and Statistical Analyses
-----------------------------

Histopathology results from US-guided core needle biopsy, vacuum-assisted excision, or surgery was considered to be the standard reference. For high-risk breast lesions, including atypical ductal hyperplasia, atypical lobular hyperplasia, lobular carcinoma *in situ*, intraductal papilloma, mucocele-like lesion, or radial scar, final pathological diagnosis of surgery was used. Final pathologic diagnosis of high-risk lesions was considered benign for statistical analysis.

The final assessment data given by S-Detect were in dichotomized form, possibly benign and possibly malignant, and for statistical analysis the final assessments made by the radiologist were dichotomized in two ways: (1) cutoff set at category 4a: negative (possibly benign), consisting of masses of category 2 and 3, positive (possibly malignant), consisting of categories 4a to 5; and (2) cutoff set at category 4b: negative consisting of category 2, 3, and 4a, and positive consisting of categories 4b to 5. Kappa statistics were used to analyze the agreement for US descriptors and final assessment between the radiologist and S-Detect. Estimation of the overall kappa was based on the study of Landis and Koch \[[@b9-usg-16012]\]: a kappa value of less than 0 indicates poor agreement. Kappa values less than or equal to 0.20 are considered slight agreement; values of 0.21-0.40 are considered fair agreement; values of 0.41-0.60, moderate agreement; values of 0.61-0.80, substantial agreement; and values of 0.81-1.00, almost perfect agreement \[[@b9-usg-16012]\]. Diagnostic performance of the radiologist and S-Detect was calculated, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy, and compared using the generalized estimating equation method. Area under the receiver operator characteristics curve (AUC) was obtained and compared by Delong's method.

Statistical analyses was performed using SAS ver. 9.2 (SAS Inc., Cary, NC, USA). All tests were two-sided, and P-values of less than 0.05 were considered to indicate statistical significance.

Results
=======

Among the 192 breast masses, 72 (37.5%) were malignant, and 120 (62.5%) were benign. Fifty-three (27.6%) lesions were diagnosed with surgery, eight (4.2%) with vacuum-assisted excision, and 118 (61.5%) with US-guided core needle biopsy. Thirteen lesions (6.7%) were included based on prior benign biopsy results and stability for more than 24 months (n=8) or typically benign US phenomena such as cysts (n=5).

Histopathologic diagnoses are shown in [Table 1](#t1-usg-16012){ref-type="table"}. The mean size of malignant masses was significantly larger than that of benign masses, 19.7±11.5 mm and 11.9±6.9 mm, respectively (P\<0.001). [Table 2](#t2-usg-16012){ref-type="table"} summarizes the proportion of S-Detect categories among each BI-RADS final assessment by the radiologist. Malignant masses had higher rates of possibly malignant assessment on S-Detect in categories 4a to 4c, but without statistical significance (all P\>0.05). Benign masses among category 4a had higher rates of probably benign assessment on S-Detect, 63.5% to 36.5%, respectively.

Diagnostic Performance of the Radiologist and S-Detect
------------------------------------------------------

Diagnostic performance of the radiologist and S-Detect is summarized in [Table 3](#t3-usg-16012){ref-type="table"}. When the cutoff was set at category 4a for the radiologist, sensitivity (100.0% to 79.2%) and NPV (100.0% to 84.0%) were significantly higher for the radiologist than for S-Detect (all P\<0.05). On the other hand, specificity (65.8% to 30.9%), PPV (58.3% to 46.2%), and accuracy (70.8% to 56.2%) were significantly higher for S-Detect than the radiologist (all P\<0.05, respectively). When the cutoff was set at category 4b for the radiologist, specificity (93.3% to 65.8%), PPV (87.3% to 58.3%), and accuracy (87.0% to 70.8%) were significantly higher for the radiologist than for S-Detect (all P\<0.05, respectively). AUC was significantly higher for S-Detect than the radiologist when the cutoff was set at category 4a, 0.725 to 0.653 (P=0.038), but did not show significant differences when the cutoff was set at category 4b (P=0.775) ([Fig. 2](#f2-usg-16012){ref-type="fig"}).

Interobserver Agreement for US Descriptors and Final Assessment
---------------------------------------------------------------

Agreement between the radiologist and S-Detect using US descriptors for breast masses is summarized in [Table 4](#t4-usg-16012){ref-type="table"}: agreement was substantial for shape (k=0.64) and orientation (k=0.61), and fair for margin (k=0.30), echo pattern (k=0.34), lesion boundary (k=0.26), and posterior features (k=0.29). Moderate agreement (k=0.58) was seen between the radiologist and S-Detect in the dichotomized final assessment.

Discussion
==========

US BI-RADS has contributed greatly to improving communication between physicians and radiologists, but still, observer variability acts as a major limitation of US, which is considered problematic considering the wide application of breast US. As technology has evolved, many adjunctive tools for breast US have been developed that may aid image interpretation and decision making based on this interpretation, including elastography \[[@b10-usg-16012]\] or computer-aided diagnosis or detection \[[@b11-usg-16012]-[@b13-usg-16012]\]. In this study, we have evaluated the diagnostic performance of a computer-aided diagnosis program, S-Detect, in the differential diagnosis of breast masses seen on US.

S-Detect had significantly higher specificity, PPV, and accuracy than a radiologist, as well as a higher AUC (all P\<0.05), when the cutoff was set at category 4a for the radiologist. In addition, malignant masses among category 4a to 4c had higher rates of possibly malignant assessment while benign masses in category 4a had higher rates of probably benign assessment on S-Detect, although without statistical significance. Approximately 90% of category 4a masses are eventually proven to be benign, and when applying S-Detect to category 4a lesions, 52.8% (47 of 89) of the benign masses may have avoided invasive biopsy procedures. But in contrast, nine of the 56 category 4a lesions assessed as possibly benign on S-Detect were confirmed as malignant. S-Detect may enable improvement of the specificity of US, but as seen in our results, this carries with it a decrease in sensitivity, which must be taken into consideration when applying S-Detect in clinical practice. Due to this tradeoff, S-Detect should be considered an adjunct to breast US, not one to replace grayscale US assessment.

As mentioned above, the majority of category 4a masses are eventually provenbenign, which considerably affects the diagnostic performance of the radiologist if the cutoff for dichotomization of final assessment categories is set at category 4a. With this in mind, the diagnostic performance of the radiologist with the cutoff set at category 4b was calculated and compared to the performance of S-Detect. With the cutoff at category 4b, the radiologist had significantly higher specificity, PPV, accuracy, and AUC compared to S-Detect (all P\<0.05). Since the present form of S-Detect provides dichotomized data, the BI-RADS final assessment categories of the radiologist also had been dichotomized for comparison, which was significantly affected by the cutoff level set for analysis of our results. As biopsy is recommended for breast masses assessed as category 4a or higher in clinical practice, diagnostic performance of the radiologist with the cutoff set at category 4a may be more representative for everyday clinical practice, where S-Detect can be considered to provide additional information regarding differential diagnosis for breast masses, serving as a second opinion provider during practice.

Kappa values for each BI-RADS US lexicon descriptor and final assessment between radiologists has been reported to show fair or moderate agreement (0.24-0.41) in the literature \[[@b2-usg-16012],[@b14-usg-16012],[@b15-usg-16012]\]. Fair to substantial agreement was seen for US descriptors between the radiologist and S-Detect ranging from 0.29 to 0.64. Moderate agreement was observed for shape and orientation, consistent with previous reports on observer agreement between radiologists \[[@b2-usg-16012],[@b15-usg-16012]\], while agreement for margin and lesion boundary was fair, k=0.30 and k=0.26, respectively, lower than the agreements of the previous reports. Differences in agreement between the prior reports and our study reflect the analytic algorithm used in S-Detect for image interpretation. For instance, the average grayscale differences between tissue/mass area or between posterior/mass area were used for analysis, which may explain the fair agreement regarding margin and lesion boundary. But more importantly, moderate agreement, k=0.58, was seen for the dichotomized final assessment showing that the decision making of S-Detect for a breast mass detected on US was quite similar to that of a dedicated breast radiologist, supporting its potential in providing guidance to radiologists with less experience in breast imaging. Further studies with a larger number of cases are anticipated to evaluate the most effective algorithm for computer-aided diagnosis in breast US.

There are several limitations to this study. First, the analysis of US features was based on the fourth edition of the BI-RADS lexicon, since S-Detect implemented the descriptors of the fourth edition in its analysis. Although little has changed between the fourth and fifth edition of BI-RADS, changes in details may have resulted in different results. Second, analysis of calcifications, which is an important clue in the diagnosis of breast cancer \[[@b16-usg-16012]\], was not performed with S-Detect. Third, non-mass lesions were excluded from the study population since analysis was limited for non-mass lesions using S-detect. Finally, one radiologist selected the representative image and confirmed or drew a ROI for S-Detect analysis, which could have differed if other radiologists had been included. The results of our study may also have differed if radiologists with different degrees of experience had been involved in review and analysis of the sonograms.

In conclusion, S-Detect may be used as an additional diagnostic tool to improve the specificity of breast US in clinical practice, and as a guide in decision making for breast masses detected on US.
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![Representative image showing the setting of the region-of-interest (ROI) for S-Detect analysis.\
After the ROI was drawn along the border of the mass, ultrasonographic features were analyzed automatically by the S-Detect program and a final assessment was produced.](usg-16012-f1){#f1-usg-16012}

![Receiver operator characteristic (ROC) curve for the radiologist and S-Detect.\
Solid blue line, brown interrupted line, and orange interrupted line indicates area under the ROC curve of radiologist with cutoff at ultrasonography (US) Breast Imaging Reporting and Data System (BI-RADS) category 4a (0.653), performance of radiologist with cutoff set at US BI-RADS category 4b (0.772), and area under the ROC curve of S-Detect (0.725), respectively.](usg-16012-f2){#f2-usg-16012}

###### 

Pathologic diagnosis of the 192 breast masses included

  Diagnosis                                          Pathology                     No. (%)
  -------------------------------------------------- ----------------------------- ---------
  Benign (n=120)                                     Atypical ductal hyperplasia   3 (2.5)
  Apocrine metaplasia                                7 (5.8)                       
  Benign phyllodes tumor                             1 (0.8)                       
  Cyst[^a)^](#tfn1-usg-16012){ref-type="table-fn"}   6 (5.0)                       
  Fibroadenoma                                       46 (38.3)                     
  Fibroadenomatoid hyperplasia                       16 (13.3)                     
  Fibrocystic change                                 3 (2.5)                       
  Fat necrosis                                       4 (3.3)                       
  Inflammation                                       5 (4.2)                       
  Intraductal papilloma                              7 (5.8)                       
  Mucocele-like lesion                               1 (0.8)                       
  Radial scar                                        3 (2.5)                       
  Sclerosing adenosis                                8 (6.7)                       
  Stability for more than 24 months                  8 (6.7)                       
  Stromal fibrosis                                   2 (1.7)                       
  Malignant (n=72)                                   Ductal carcinoma *in situ*    7 (9.7)
  Invasive ductal carcinoma                          56 (77.8)                     
  Invasive lobular carcinoma                         2 (2.8)                       
  Medullary carcinoma                                1 (1.4)                       
  Mucinous carcinoma                                 3 (4.2)                       
  Tubular carcinoma                                  3 (4.2)                       

Including five cysts diagnosed based on typical ultrasonographic features, without biopsy.

###### 

Distribution of final assessments of the 192 breast masses according to the radiologist and S-Detect

  Radiologist   Pathology    S-Detect    P-value                 
  ------------- ------------ ----------- ----------- ----------- -------
  Category 2                                         10 (5.2)    \-
                Benign       7 (70.0)    3 (30.0)                
                Malignancy   0           0                       
  Category 3                                         26 (13.5)   \-
                Benign       18 (69.2)   8 (30.8)                
                Malignancy   0           0                       
  Category 4a                                        89 (46.4)   0.797
                Benign       47 (63.5)   27 (36.5)               
                Malignancy   9 (60.0)    6 (40.0)                
  Category 4b                                        11 (5.8)    0.953
                Benign       5 (71.4)    2 (28.6)                
                Malignancy   2 (50.0)    2 (50.0)                
  Category 4c                                        19 (9.9)    0.310
                Benign       2 (66.7)    1 (33.3)                
                Malignancy   3 (18.7)    13 (81.3)               
  Category 5                                         37 (19.2)   \-
                Benign       0           0                       
                Malignancy   1 (2.7)     36 (97.3)               

Values are presented as number (%).

###### 

Diagnostic performance of the radiologist and S-Detect

  Variable          S-Detect        Radiologist[^a)^](#tfn4-usg-16012){ref-type="table-fn"}   P-value   Radiologist[^b)^](#tfn5-usg-16012){ref-type="table-fn"}   P-value
  ----------------- --------------- --------------------------------------------------------- --------- --------------------------------------------------------- ---------
  Sensitivity (%)   79.2            100.0                                                     \<0.001   76.4                                                      0.824
  Specificity (%)   65.8            30.9                                                      \<0.001   93.3                                                      \<0.001
  PPV (%)           58.3            46.2                                                      0.002     87.3                                                      \<0.001
  NPV (%)           84.0            100.0                                                     0.005     86.8                                                      0.873
  Accuracy          70.8            56.2                                                      0.002     87.0                                                      0.001
  AUC (95% CI, %)   0.725           0.653                                                     0.038     0.772                                                     0.775
                    (0.661-0.789)   (0.603-0.688)                                                       (0.706-0.830)                                             

PPV, positive predictive value; NPV, negative predictive value; AUC, area under the receiver operating characteristics curve; CI, confidence interval; US, ultrasonography; BIRADS, Breast Imaging Reporting and Data System.

US BI-RADS category 2-3 considered negative, categories 4a-5 considered positive.

US BI-RADS category 2-4a considered negative, categories 4b-5 considered positive

###### 

Agreement on US descriptors and final assessment between the radiologist and S-Detect

  US feature           k value (95% CI)     
  -------------------- -------------------- ------------------
  Shape                Oval                 0.64 (0.54-0.73)
                       Round                
                       Lobular              
                       Irregular            
  Margin               Circumscribed        0.30 (0.20-0.40)
                       Indistinct           
                       Angular              
                       Microlobulated       
                       Spiculated           
  Echo pattern         Anechoic             0.34 (0.18-0.49)
                       Hyperechoic          
                       Isoechoic            
                       Hypoechoic           
                       Complex              
  Orientation          Parallel             0.61 (0.49-0.73)
                       Not parallel         
  Lesion boundary      Abrupt interface     0.26 (0.11-0.41)
                       Echogenic halo       
  Posterior features   Absent               0.29 (0.16-0.41)
                       Enhancement          
                       Shadowing            
                       Combined             
  Final assessment     Possibly benign      0.58 (0.47-0.69)
                       Possibly malignant   

US, ultrasonography; CI, confidence interval.
